Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dantrolene for Ventricular Arrhythmias in Structural Heart Disease
NCT04134845Phase 3Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Aug 2020
- Primary completion
- May 2025
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in ventricular tachycardia (VT) comparing Dantrolene/Ryanodex with Placebo (2 arms). Primary endpoint: Number of Participants With Inducible Sustained Ventricular Tachycardia/ Ventricular Fibrillation at 10 minutes. Started Aug 2020; status: completed.
02
Drugs
dantrolene
03
Conditions
ventricular tachycardia (VT)
Beyond the preview
Go deeper on NCT04134845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04134845.